MIDDLETOWN, Pa.–(BUSINESS WIRE)– #DryAMD–OpZira™, Inc., an ophthalmic medical device company advancing technologies for the detection and monitoring of ocular disease, today announced its subsidiary, AdaptDx, Inc., has completed its Stage II audit at the company’s Lighthouse medical device manufacturing facility. The audit represents an important step in the ISO certification process and supports OpZira’s plans to pursue CE marking for AdaptDx Pro® in the European Union in 2027.AdaptDx Pro is a portabl